Shares of Neuland Laboratories Ltd. rallied over 8% to reach a day’s high of Rs 13,630.00 on 27th September, following the USFDA approval of Bristol...
India’s second-largest drugmaker by revenue, Dr. Reddy will sell its U.S. and select territory rights for Zembrace and Tosymra (used for treating migraine), which were...
Zydus Cadila has received final approval from the US health regulator to market Dutasteride and Tamsulosin Hydrochloride capsules. It is used to treat symptoms of Benign...
Orchid Pharma receives approval for Aripiprazole Orally-Disintegrating tablets from the US health regulator. The company in a filing to BSE stated it, “has received ANDA (abbreviated...
Cadila Healthcare’s subsidiary, has received approval from the US health regulator for Clozapine tablets, which is used to treat schizophrenia. In a filing the company stated,...
Zydus Cadila has received final approval to market Candesartan Cilexetil and Hydrochlorothiazide tablets formulations, from the US health regulator. It is used for treating high blood...
Dr Reddy’s Laboratories Ltd has launched Clofarabine Injection, in the United States market, a remedy which is identical generic version of Clolar (clofarabine) Injection. The generic version of the injection is...
Panacea Biotec has declared the launch of generic version of anti-platelet medication Prasugrel 5mg and 10mg tablets in US. Panacea’s Prasugrel copies are first to file abbreviated new...